Table 1.
Baseline characteristics of CMI patients and controls
| CMI (n=12) | Controls (n=12) | |
|---|---|---|
| Agea | 63.2 (48.8–70.4) | 32.7 (27.7–38.1) |
| Gender | ||
| Male | 8 (67) | 5 (42) |
| Female | 4 (33) | 7 (58) |
| BMI (kg/m2)a | 24.2 (21.5–28.3) | 22.3 (20.4–24.8) |
| Symptomatology | ||
| Abdominal pain | 10 (83) | 0 |
| Postprandial pain | 9 (75) | 0 |
| Exercise-induced pain | 4 (33) | 0 |
| Weight loss | 7 (58) | 0 |
| Weight loss (kg/months)a | 2.0 (1.1–3.0) | 0 |
| Diarrhea | 2 (17) | 0 |
| Nausea | 5 (42) | 0 |
| Duration of symptoms (months)a | 10.0 (6.0–21.0) | 0 |
| Cardiovascular comorbidity | ||
| History of CVD | 8 (67) | 0 |
| CAD alone | 0 (0) | 0 |
| PAD alone | 4 (33) | 0 |
| Both | 4 (33) | 0 |
| Hypertension | 7 (58) | 0 |
| DM type II | 3 (25) | 0 |
| Hypercholesterolemia | 6 (50) | 0 |
| Family history of CVD | 5 (42) | 0 |
| Smokingb | 10 (83) | 4 (40) |
| Current | 6 (50) | 1 (8) |
| Former | 4 (33) | 3 (25) |
| Pack yearsa | 162 (0–356) | 0 |
| Alcohol use | 6 (50) | 8 (67) |
| Alcohol (U/day)c | 0 (0–1.8) | 0.6 (0–1.0) |
| Mesenteric artery stenosisd | ||
| No stenosis | 1 (8) | 0 |
| Single artery stenosis | 4 (33) | 0 |
| Multi artery stenosis | 7 (58) | 0 |
| VLS measurement | ||
| Antruma | 58.5 (53.5–59.0) | 61.5 (60.0–63.0) |
| Duodenal bulba | 53.0 (48.8–54.0) | 59.0 (54.0–63.8) |
| Descending duodenuma | 49.5 (45.3–52.8) | 51.5 (47.5–56.0) |
Notes: Values represent the number and percentage of patients unless otherwise specified.
a
Median, IQR.
b
Includes current and former smokers.
c
Median, range.
d
Stenosis of the mesenteric arteries is defined as >70% lumen reduction on CTA or MRA.
Abbreviations: BMI, body max index; CAD, cardial arterial disease; CMI, chronic mesenteric ischemia; CTA, computed tomography angiography; CVD, cardiovascular disease; DM, diabetes mellitus; MRA, magnetic resonance angiography; PAD, peripheral arterial disease; VLS, visible light spectroscopy.